title: Dual function of tributyrin emulsion: solubilization and enhancement of anticancer effect of celecoxib.
abstract: Tributyrin, a triglyceride analogue of butyrate, can act as a prodrug of an anticancer agent butyrate after being cleaved by intracellular enzymes. We recently demonstrated that the emulsion containing tributyrin as an inner oil phase possesses a potent anticancer activity. Herein we sought to develop tributyrin emulsion as a carrier of celecoxib, a poorly-water soluble drug with anticancer activity. Combined treatment of human HCT116 colon cancer cells with free celecoxib plus tributyrin emulsion inhibited the cellular proliferation more effectively than that of each drug alone, suggesting the possibility of tributyrin emulsion as a potential celecoxib carrier. The mean droplet size of emulsions tended to increase as the tributyrin content in emulsion increases and the concentration of celecoxib loaded in emulsions was affected by tributyrin content and the initial amount of celecoxib, but not by the total amount of surfactant mixture. The concentration of celecoxib required to inhibit the growth of HCT116 and B16-F10 cancer cells by 50% was 2.6- and 3.1-fold lowered by loading celecoxib in tributyrin emulsions, compared with free celecoxib. These data suggest that the anticancer activity of celecoxib was enhanced by loading in tributyrin emulsions, probably due to the solubilization capacity and anticancer activity of tributyrin emulsion.
authors.affiliation: Department of Bioscience and Biotechnology, Sejong University, 98 Kunja-dong, Kwangjin-gu, Seoul 143-747, Republic of Korea.
authors.forename: Sung Nam
authors.initials: SN
authors.lastname: Kang
authors.forename: Soon-Seok
authors.initials: SS
authors.lastname: Hong
authors.forename: Mi-Kyung
authors.initials: MK
authors.lastname: Lee
authors.forename: Soo-Jeong
authors.initials: SJ
authors.lastname: Lim
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology*; D000068579:Celecoxib; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy; D004337:Drug Carriers / Q000737:chemistry / Q000494:pharmacology; D004357:Drug Synergism; D004655:Emulsions / Q000737:chemistry / Q000494:pharmacology; D045325:HCT116 Cells; D006801:Humans; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D009821:Oils / Q000737:chemistry; D010316:Particle Size; D011355:Prodrugs / Q000737:chemistry / Q000494:pharmacology; D011720:Pyrazoles / Q000737:chemistry* / Q000494:pharmacology*; D012995:Solubility; D013449:Sulfonamides / Q000737:chemistry* / Q000494:pharmacology*; D013501:Surface-Active Agents / Q000737:chemistry; D014280:Triglycerides / Q000737:chemistry* / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D004655:Emulsions; D009821:Oils; D011355:Prodrugs; D011720:Pyrazoles; D013449:Sulfonamides; D013501:Surface-Active Agents; D014280:Triglycerides; D000068579:Celecoxib; C005830:tributyrin